Non-Responsive Diabetic Macular Edema and Spironolactone

NCT04853355 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped lack of funding

Conditions

Diabetic Maculopathy

Interventions

DRUG: Spironolactone 50 mg

Sponsor

Wake Forest University Health Sciences